Main navigation
Search Results
-
Event - - Lille, France, Kongress/Symposiumhttps://www.gesundheitsindustrie-bw.de/en/event/medfit-2024 -
Event - - BioFIT 2024
Lille, Frankreich, Kongress/Symposiumhttps://www.gesundheitsindustrie-bw.de/en/event/biofit-2024 -
Press release - 03/07/2024 Max Planck scientists develop cost-efficient medical imaging method
Max Planck scientists will present a low-field magnetic resonance imaging (MRI) scanner in Lindau. Two researchers from the MPI for Biological Cybernetics in Tübingen, Germany, will present a model of a new low-field MRI system. It combines hyperpolarization with imaging techniques that can be run at low magnetic field strengths. The quality of the MRI images can be enhanced with the help of artificial intelligence.
https://www.gesundheitsindustrie-bw.de/en/article/press-release/max-planck-scientists-develop-cost-efficient-medical-imaging-method -
Press release - 03/07/2024 Advancement Award for Heidelberg Molecular Biologist
For her ground-breaking scientific studies in the field of synthetic biology, the 2024 Alfried Krupp Advancement Award is to go to Prof. Dr Kerstin Göpfrich. The award, endowed with one million euros in funding, is granted annually by the Alfried Krupp von Bohlen und Halbach Foundation to young academics holding their first professorship in the natural and engineering sciences.
https://www.gesundheitsindustrie-bw.de/en/article/press-release/advancement-award-heidelberg-molecular-biologist -
Press release - 03/07/2024 CureVac Initiates Strategic Restructuring to Align Resources with Focus on High-Value mRNA Pipeline Opportunities
CureVac N.V. (Nasdaq: CVAC) (“CureVac”), a global biopharmaceutical company developing a new class of transformative medicines based on messenger ribonucleic acid (“mRNA”), today announced a significant strategic restructuring to focus its resources on high-value mRNA projects in oncology and other select areas of substantial unmet medical need.
https://www.gesundheitsindustrie-bw.de/en/article/press-release/curevac-initiates-strategic-restructuring-align-resources-focus-high-value-mrna-pipeline-opportunities -
Press release - 02/07/2024 Artificial intelligence helps physicians make precise heart diagnoses
Researchers from the University of Heidelberg have published a study on more than 60,000 patients in the renowned journal Lancet Digital Health, demonstrating the potential of AI in cardiac medicine.
https://www.gesundheitsindustrie-bw.de/en/article/press-release/artificial-intelligence-helps-physicians-make-precise-heart-diagnoses -
Press release - 02/07/2024 Faster use of new technologies in rehabilitation
BioRegio STERN Management GmbH is a partner in the new RehAllianCE project, which is being funded by the EU as part of the Interreg CENTRAL EUROPE program. The focus is on the use of new technologies in rehabilitation to improve patient care. The aim is to increase the innovation capacities of SMEs so that aids such as rehabilitation robots, exoskeletons etc. can be used more quickly.
https://www.gesundheitsindustrie-bw.de/en/article/press-release/faster-use-new-technologies-rehabilitation -
Press release - 02/07/2024 DKFZ spin-off Epignostix raises €4.3m seed round to commercialize diagnostic tumor classifier
Heidelberg Epignostix GmbH, a deeptech start-up committed to precision cancer diagnostics today announces €4.3M in seed funding. This investment will enable Heidelberg Epignostix to make a substantial leap forward in driving market development for its flagship indication for brain tumor classification.
https://www.gesundheitsindustrie-bw.de/en/article/press-release/dkfz-spin-epignostix-raises-euro-43m-seed-round-commercialize-diagnostic-tumor-classifier -
Baden-Württemberg receives the EU Commission's "Regional Innovation Valley" label - 01/07/2024 Customised healthcare for all: BIOPRO is a partner in the EU project PRECISEU
The EU research project PRECISEU, which started in June 2024 and will run for five years, aims to connect innovation ecosystems across Europe and advance personalised medicine throughout Europe. BIOPRO Baden-Württemberg is one of 25 partner organisations from 11 European countries that are working on the further development of customised healthcare as part of the research project.
https://www.gesundheitsindustrie-bw.de/en/article/press-release/customised-healthcare-all-biopro-partner-eu-project-preciseu -
Baden-Württemberg receives the EU Commission's "Regional Innovation Valley" label - 01/07/2024 Customised healthcare for all: BIOPRO is a partner in the EU project PRECISEU
The EU research project PRECISEU, which started in June 2024 and will run for five years, aims to connect innovation ecosystems across Europe and advance personalised medicine throughout Europe. BIOPRO Baden-Württemberg is one of 25 partner organisations from 11 European countries that are working on the further development of customised healthcare as part of the research project.
https://www.bio-pro.de/en/information/press-release/customised-healthcare-all-biopro-partner-eu-project-preciseu -
Press release - 24/06/2024 Digital babies created to improve infant healthcare
Researchers at University of Galway, the Heidelberg Institute for Theoretical Studies (HITS) Heidelberg University, and Heidelberg University Hospital have created digital babies to better understand infants’ health in their critical first 180 days of life. The international team created computer models that simulate the unique metabolic processes of each baby. The models can help to better understand rare metabolic diseases.
https://www.gesundheitsindustrie-bw.de/en/article/press-release/digital-babies-created-improve-infant-healthcare -
Press release - 24/06/2024 Trustworthy AI Made in Mannheim
How can we use artificial intelligence (AI) to make comprehensible medical decisions? A new project at the University of Mannheim, which has received funding from the Federal Ministry of Education and Research (BMBF), will analyze this question.
https://www.gesundheitsindustrie-bw.de/en/article/press-release/trustworthy-ai-made-mannheim -
Press release - 21/06/2024 Cyber Valley: World's first ELLIS Institute opens
At the finale of the Cyber Valley Days, and Science Minister Petra Olschowski opened the ELLIS Institute Tübingen, heralding the next phase of the AI Innovation Campus. With the world's first ELLIS Institute, Cyber Valley is gaining further radiance. Olschowski also announced at the ceremony that the Karlsruhe Institute of Technology (KIT) is joining the Cyber Valley Community.
https://www.gesundheitsindustrie-bw.de/en/article/press-release/cyber-valley-worlds-first-ellis-institute-opens -
Press release - 21/06/2024 New tool maps microbial diversity with unprecedented details
Researchers from the Max Planck Institute for Biology Tübingen developed the groundbreaking tool SynTracker. SynTracker expands traditional microbial analysis by considering genomic structural variation to complement existing SNP-based methods. This innovation reveals more precision and depths of microbial strain diversity and evolution.
https://www.gesundheitsindustrie-bw.de/en/article/press-release/new-tool-maps-microbial-diversity-unprecedented-details -
Gender-specific differences - 18/06/2024 Gender medicine: Why is good healthcare not a matter of course for everyone?
Gender medicine is the study of gender-specific health differences. Many diseases manifest themselves differently in men and women and therapies do not always have the same effect depending on the sex of the patient being treated. There is currently not enough data on these differences. Research teams including the one led by Professor Dr. Dr. Sonja Loges from the University Medical Centre Mannheim and the DKFZ are seeking to change this.
https://www.gesundheitsindustrie-bw.de/en/article/news/gender-medicine-why-good-healthcare-not-matter-course-everyone -
Event - Life Science Investors’ Day 2024
Heidelberg , Informationsveranstaltunghttps://www.gesundheitsindustrie-bw.de/en/event/life-science-investors-day-2024 -
Event - BioRN Annual Conference 2024
Heidelberg , Informationsveranstaltunghttps://www.gesundheitsindustrie-bw.de/en/event/biorn-annual-conference-2024 -
Press release - 17/06/2024 DNA as building material for tiny machines and artificial cells
Humboldt Research Award winner Prof. Hao Yan has been conducting research at the 2nd Institute of Physics at the University of Stuttgart since May. He is regarded as one of the world's leading experts in the field of DNA nanotechnology. "My work has many points of commonality with the topics that my colleagues in Stuttgart are focusing on," says Yan. "I have therefore been cooperating with Professor Laura Na Liu's working…
https://www.gesundheitsindustrie-bw.de/en/article/press-release/dna-building-material-tiny-machines-and-artificial-cells -
Press release - 13/06/2024 Eyesight from a 3D Printer
Printing a new cornea during an operation to restore a patient’s eyesight: This groundbreaking step in the fight against corneal disorders is set to become reality with a laser based process using personalized bioink. The method was developed by researchers at the Karlsruhe Institute of Technology (KIT) in collaboration with Carl Zeiss Meditec AG and Evonik Healthcare. Their project won the idea award in this year’s NEULAND innovation contest.
https://www.gesundheitsindustrie-bw.de/en/article/press-release/eyesight-3d-printer -
Press release - 13/06/2024 Which of the two DNA strands is damaged influences the cell's mutation profile
Cancer genomes are the result of diverse mutation processes. Scientists have analyzed the molecular evolution of tumors after exposure to mutagenic chemicals. DNA lesions that persists unrepaired over several cell generations lead to sequence variations at the site of damage. This enabled the researchers to distinguish the contribution of the triggering lesion from that of the subsequent repair in shaping the mutation pattern.
https://www.gesundheitsindustrie-bw.de/en/article/press-release/which-two-dna-strands-damaged-influences-cells-mutation-profile -
Press release - 13/06/2024 Position of the cell nucleus affects epigenetics and therefore gene activity and cell function
Depending on whether the cell nucleus of an epithelial cell is located on the outer or inner side of the tissue, the genome is more or less acetylated - genes can therefore be translated easier or harder. Scientists from the German Cancer Research Center (DKFZ) have demonstrated this for the first time in the development of the Drosophila wing.
https://www.gesundheitsindustrie-bw.de/en/article/press-release/position-cell-nucleus-affects-epigenetics-and-therefore-gene-activity-and-cell-function -
Press release - 13/06/2024 BioRegio STERN receives 2024 award for best ZIM innovation network
BioRegio STERN Management GmbH was today presented with an award at the Innovation Day for SMEs held by Germany’s Federal Ministry for Economic Affairs and Climate Action. Its “biohymed” project was named the year’s best innovation network under the Central Innovation Programme for SMEs (ZIM).
https://www.gesundheitsindustrie-bw.de/en/article/press-release/bioregio-stern-receives-2024-award-best-zim-innovation-network -
Press release - 12/06/2024 Pathogen identification — next-generation sequencing optimizes diagnostics
Invasive infections such as sepsis require immediate and targeted treatment. Experts from the Fraunhofer Institute for Interfacial Engineering and Biotechnology IGB and group partners have succeeded in establishing a reconceptualized detection principle that can make a crucial contribution to saving lives through fast, ultra-accurate pathogen identification. They have been chosen to receive the 2024 Stifterverband Science Prize for their efforts.
https://www.gesundheitsindustrie-bw.de/en/article/press-release/pathogen-identification-next-generation-sequencing-optimizes-diagnostics -
Press release - 07/06/2024 German Research Foundation honors researchers for animal testing alternatives
Prof. Dr. Peter Loskill and Dr. Silke Riegger from the 3R Center Tübingen for in-vitro models and animal testing alternatives have been awarded the Ursula M. Händel Animal Welfare Prize 2024. The prize, endowed with 80,000 euros, was awarded to them in Würzburg for the development of organ-on-chip (OoC) systems as an alternative to animal testing.
https://www.gesundheitsindustrie-bw.de/en/article/press-release/german-research-foundation-honors-researchers-animal-testing-alternatives -
Press release - 06/06/2024 Festo Expands its Portfolio with Multilayer Manifolds
Festo is expanding its portfolio to include multilayer manifolds made of plastic (bonded manifolds) in order to be able to offer manufacturers of medical and laboratory equipment solutions from a single source. To this end, Festo is taking over the production systems and processes for manufacturing these complex plastic manifolds from Carville, a leading company in this field.
https://www.gesundheitsindustrie-bw.de/en/article/press-release/festo-expands-its-portfolio-multilayer-manifolds